The Vanguard Group 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 2:47 pm Purchase | 2025-12-31 | 13G | VistaGen Therapeutics, Inc. VTGN | The Vanguard Group | 1,824,738 4.620% | 137,003 (+8.12%) | Filing |
| 2025-10-31 11:41 am Sale | 2025-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | The Vanguard Group | 1,687,735 5.500% | -146,777 (-8.00%) | Filing |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | VistaGen Therapeutics, Inc. VTGN | The Vanguard Group | 1,834,512 6.790% | 1,834,512 (New Position) | Filing |